The association between CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) and Melanoma, Cutaneous Malignant 1 is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording pathogenic and likely-pathogenic variants and a susceptibility locus.
Sources3
Clinical variants931
Symptoms22
Compounds0
Trials0
Publications194
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.